What's new

EU Innovation Network (EU-IN)

EU Innovation Network (EU-IN)

Feb 13, 2025 0

EU Innovation Network (EU-IN)

EMEA-003174-PIP01-21-M01

EMEA-003174-PIP01-21-M01

Feb 13, 2025 0

EMEA-003174-PIP01-21-M01

Human medicines European public assessment report (EPAR): Dimethyl fumarate Neuraxpharm, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025 0

Human medicines European public assessment report (EPAR): Dimethyl fumarate Neur...

Human medicines European public assessment report (EPAR): Nimenrix, meningococcal groups A, C, W-135 and Y conjugate vaccine, Date of authorisation: 20/04/2012, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025 0

Human medicines European public assessment report (EPAR): Nimenrix, meningococca...

Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025 0

Human medicines European public assessment report (EPAR): Ruxience, rituximab, D...

EMEA-003469-PIP01-23

EMEA-003469-PIP01-23

Feb 13, 2025 0

EMEA-003469-PIP01-23

Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025 0

Human medicines European public assessment report (EPAR): Ozempic, semaglutide, ...

EMEA-003496-PIP01-23

EMEA-003496-PIP01-23

Feb 13, 2025 0

EMEA-003496-PIP01-23

EMEA-003396-PIP01-23

EMEA-003396-PIP01-23

Feb 13, 2025 0

EMEA-003396-PIP01-23

EMEA-002674-PIP01-19

EMEA-002674-PIP01-19

Feb 13, 2025 0

EMEA-002674-PIP01-19

EMEA-002022-PIP02-23

EMEA-002022-PIP02-23

Feb 13, 2025 0

EMEA-002022-PIP02-23

EMEA-003507-PIP01-23

EMEA-003507-PIP01-23

Feb 13, 2025 0

EMEA-003507-PIP01-23

EMEA-003499-PIP01-23

EMEA-003499-PIP01-23

Feb 13, 2025 0

EMEA-003499-PIP01-23

EMEA-003497-PIP01-23

EMEA-003497-PIP01-23

Feb 13, 2025 0

EMEA-003497-PIP01-23

EMEA-003419-PIP01-23

EMEA-003419-PIP01-23

Feb 13, 2025 0

EMEA-003419-PIP01-23

EMEA-003025-PIP03-23-M01

EMEA-003025-PIP03-23-M01

Feb 13, 2025 0

EMEA-003025-PIP03-23-M01

EMEA-003071-PIP02-23

EMEA-003071-PIP02-23

Feb 13, 2025 0

EMEA-003071-PIP02-23

Overview of the current regulatory testing requirements for medicinal products for human use and opportunities for implementation of the 3Rs - Scientific guideline

Overview of the current regulatory testing requirements...

Feb 13, 2025 0

Overview of the current regulatory testing requirements for medicinal products f...

Overview of the current regulatory testing requirements for veterinary medicinal products and opportunities for implementation of the 3Rs - Scientific guideline

Overview of the current regulatory testing requirements...

Feb 13, 2025 0

Overview of the current regulatory testing requirements for veterinary medicinal...

Quarterly System Demo – Q1 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 March 2025, 09:00 (CET) to 26 March 2025, 11:30 (CET)

Quarterly System Demo – Q1 2025, Online, European Medic...

Feb 13, 2025 0

Quarterly System Demo – Q1 2025, Online, European Medicines Agency, Amsterdam, t...

EMEA-003233-PIP01-22

EMEA-003233-PIP01-22

Feb 13, 2025 0

EMEA-003233-PIP01-22

EMA Veterinary Innovation Day, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 March 2025, 13:30 (CET) to 14 March 2025, 12:30 (CET)

EMA Veterinary Innovation Day, Online, European Medicin...

Feb 13, 2025 0

EMA Veterinary Innovation Day, Online, European Medicines Agency, Amsterdam, the...

Agenda - EMA Veterinary Innovation Day - March 2025

Feb 13, 2025 0

Agenda - EMA Veterinary Innovation Day - March 2025

Opinion/decision on a Paediatric investigation plan (PIP): Filsuvez, birch bark, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0541/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 13, 2025 0

Opinion/decision on a Paediatric investigation plan (PIP): Filsuvez, birch bark,...

51
52
53
54
55

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.